<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01046890</url>
  </required_header>
  <id_info>
    <org_study_id>EQUIDAR</org_study_id>
    <nct_id>NCT01046890</nct_id>
  </id_info>
  <brief_title>Drug Interactions Between Echinacea Purpurea and Darunavir/Ritonavir</brief_title>
  <official_title>Drug Interactions Between Echinacea Purpurea and Darunavir/Ritonavir</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Germans Trias i Pujol Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>IrsiCaixa</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Germans Trias i Pujol Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this clinical trial is to characterize drug interactions between one medicinal
      herb widely used by HIV infected patients: Echinacea sp. and the protease inhibitor
      darunavir/ritonavir.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      15 patients on antiretroviral therapy with darunavir/ritonavir 600/100 mg twice a day during
      four weeks will be recruited. The patients will receive treatment with Echinacea purpurea for
      14 days, 500 mg every 6 hours. A 12 hour pharmacokinetic curve will be obtained at baseline
      and on day 14.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Actual">April 2010</completion_date>
  <primary_completion_date type="Actual">March 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>plasma concentration of darunavir and ritonavir</measure>
    <time_frame>DAY 14</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clearance (CL/F)</measure>
    <time_frame>DAY 14</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Volume of distribution (V/F)</measure>
    <time_frame>DAY 14</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Elimination half-life (t1/2)</measure>
    <time_frame>DAY 14</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Area under the plasma concentration-time curve during the dosing interval</measure>
    <time_frame>DAY 14</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events and laboratory alterations</measure>
    <time_frame>DAY 14</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HIV Viral load in plasma</measure>
    <time_frame>DAY 14</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">15</enrollment>
  <condition>HIV Infections</condition>
  <arm_group>
    <arm_group_label>darunavir/ritonavir + root of Echinacea purpurea</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>darunavir/ritonavir + root of Echinacea purpurea</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Echinacea</intervention_name>
    <description>darunavir/ritonavir 600/100 mg + root of Echinacea purpurea 500 mg every 6 hours</description>
    <arm_group_label>darunavir/ritonavir + root of Echinacea purpurea</arm_group_label>
    <other_name>N/H</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients infected with HIV-1 (at least one documented positive Western-Blot).

          2. Age =/+ 18 years.

          3. Patients receiving antiretroviral therapy containing darunavir / ritonavir at the
             approved dose of 600/100 mg twice daily for at least 4 weeks

          4. HIV viral load in plasma &lt;50 copies / mL

          5. Absence of acute infections and / or tumors in the three months prior to inclusion.

          6. Subject able to follow the treatment period, without suspicion of poor adherence in
             previous antiretroviral treatments.

          7. Voluntary written informed consent.

        Exclusion Criteria:

          1. Any clinical or historical observation that could interfere with the pharmacokinetics
             of medications, such as gastrointestinal illness or surgery (except for herniotomy and
             appendectomy), changes in the composition of plasma proteins, some indication of
             hepatic or renal dysfunction.

          2. Active alcohol consumption (&gt; 50 g / day) or illicit drugs (except cannabis).

          3. Pregnancy or lactation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jose Molt√≥, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lluita contra la Sida Foundation, HIV Unit</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Lluita contra la Sida Foundation, HIV Unit, Irsi Caixa Foundation</name>
      <address>
        <city>Badalona</city>
        <zip>08916</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>May 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 11, 2010</study_first_submitted>
  <study_first_submitted_qc>January 11, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 12, 2010</study_first_posted>
  <last_update_submitted>May 4, 2010</last_update_submitted>
  <last_update_submitted_qc>May 4, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 5, 2010</last_update_posted>
  <responsible_party>
    <name_title>Lluita Sida Foundation</name_title>
    <organization>Lluita Sida Foundation</organization>
  </responsible_party>
  <keyword>Darunavir</keyword>
  <keyword>Echinacea purpurea</keyword>
  <keyword>Interaction</keyword>
  <keyword>Complementary Therapies</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>HIV Infections</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ritonavir</mesh_term>
    <mesh_term>Darunavir</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

